Morgan Stanley’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,986
| Closed | -$89.2K | – | 8009 |
|
|
2022
Q4 | $89.2K | Sell |
7,986
-136,542
| -94% | -$1.53M | ﹤0.01% | 6032 |
|
|
2022
Q3 | $812K | Buy |
144,528
+477
| +0.3% | +$2.68K | ﹤0.01% | 5001 |
|
|
2022
Q2 | $623K | Buy |
144,051
+39,302
| +38% | +$170K | ﹤0.01% | 5308 |
|
|
2022
Q1 | $1.22M | Buy |
104,749
+32,206
| +44% | +$375K | ﹤0.01% | 4863 |
|
|
2021
Q4 | $1.33M | Sell |
72,543
-45,185
| -38% | -$825K | ﹤0.01% | 4879 |
|
|
2021
Q3 | $1.4M | Buy |
117,728
+91,566
| +350% | +$1.08M | ﹤0.01% | 4833 |
|
|
2021
Q2 | $450K | Sell |
26,162
-17,211
| -40% | -$296K | ﹤0.01% | 5593 |
|
|
2021
Q1 | $793K | Sell |
43,373
-37,523
| -46% | -$686K | ﹤0.01% | 4873 |
|
|
2020
Q4 | $1.52M | Buy |
80,896
+21,587
| +36% | +$406K | ﹤0.01% | 4385 |
|
|
2020
Q3 | $1.25M | Buy |
59,309
+23,275
| +65% | +$492K | ﹤0.01% | 4047 |
|
|
2020
Q2 | $1.04M | Buy |
36,034
+35,599
| +8,184% | +$1.03M | ﹤0.01% | 4142 |
|
|
2020
Q1 | $15K | Sell |
435
-7,115
| -94% | -$245K | ﹤0.01% | 5917 |
|
|
2019
Q4 | $185K | Buy |
+7,550
| New | +$185K | ﹤0.01% | 5449 |
|